Dr Katharine Stott
Publications for Katharine Stott
Pharmacokinetics of rifampicin in adult TB patients and healthy volunteers: a systematic review and meta-analysis
K E Stott H Pertinez M G G Sturkenboom M J Boeree R Aarnoutse G Ramachandran A Requena-Méndez C Peloquin C F N Koegelenberg J W C Alffenaar R Ruslami A Tostmann S Swaminathan H McIlleron G Davies
Therapeutic drug monitoring for invasive mould infections and disease: pharmacokinetic and pharmacodynamic considerations
Stott KE, Hope WW
Managing potential drug-drug interactions between gastric acid-reducing agents and antiretroviral therapy: experience from a large HIV-positive cohort.
Lewis JM, Stott KE, Monnery D, Seden K, Beeching NJ, Chaponda M, Khoo S, Beadsworth MB.
Brief Report: Virologic Monitoring Can Be a Cost-Effective Strategy to Diagnose Treatment Failure on First-Line ART.
Vandormael AM, Boulware DR, Tanser FC, Bärnighausen TW, Stott KE, de Oliveira T.
Adequacy of Rifampin Absorption after Jejunostomy Tube Administration.
Stott KE, Singh B, Beadsworth MB, Vaudrey K, Khoo SH, Davies G.
Clostridium difficile: A healthcare-associated infection of unknown significance in adults in sub-Saharan Africa.
Keeley AJ, Beeching NJ, Stott KE, Roberts P, Watson AJ, Beadsworth MB.